Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response

Vaccine

Volumn 27, Issue 40, 2009, Pages 5435-5442

  Brgles, Marija ^a   Habjanec, Lidija ^a   Halassy, Beata ^a   Tomašić, Jelka ^a  

^a INSTITUTE OF IMMUNOLOGY   (Croatia)

Author keywords

Adjuvants; Cationic liposomes; Entrapment efficiency; Th bias

Indexed keywords

IMMUNOLOGICAL ADJUVANT; IMMUNOSTIMULATING AGENT; LIPOSOME; OVALBUMIN; PEPTIDOGLYCAN;

ANIMAL EXPERIMENT; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; FEMALE; HUMORAL IMMUNITY; IONIC STRENGTH; MOUSE; NONHUMAN; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIGENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN G; LIPOSOMES; MICE; OVALBUMIN; PARTICLE SIZE; PEPTIDOGLYCAN; TH1 CELLS; TH2 CELLS;

EID: 68349139572     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.07.012     Document Type: Article

References (39)

1. Felnerova D., Viret J.-F., Glück R., and Moser C. Liposomes and virosomes as delivery systems for antigens, nucleic acids and drugs. Curr Opin Biotechnol 15 (2004) 518-529
2. Alving C.R. Liposomes as carriers of antigens and adjuvants. J Immunol Methods 140 (1991) 1-13
3. Christensen D., Agger E.M., Andreasen L.V., Kirby D., Andersen P., and Perrie Y. Liposome-based cationic adjuvant formulations (CAF): past, present, and future. J Liposome Res 19 (2009) 2-11
4. Chen W., Yan W., and Huang L. A simple but effective cancer vaccine consisting of an antigen and a cationic lipid. Cancer Immunol Immunother 57 (2008) 517-530
5. Habjanec L., Frkanec R., Halassy B., and Tomašić J. Effect of liposomal formulations and immunostimulating peptidoglycan monomer (PGM) on the immune reaction to ovalbumin in mice. J Liposome Res 16 (2006) 1-16
6. Nakanishi T., Kunisawa J., Hayashi A., Tatsumi Y., Kubo K., Nakagawa S., et al. Positively charged liposome funtions as an efficient immunoadjuvant in inducing immune responses to soluble proteins. Biochem Biophys Res Commun 240 (1997) 793-797
7. Nakanishi T., Kunisawa J., Hayashi A., Tsutsumi Y., Kubo K., Nakagawa S., et al. Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins. J Control Release 61 (1999) 233-240
8. Shek P.N., Yung B.Y.K., and Stanacev N.Z. Comparison between multilamelar and unilamellar liposomes in enhancing antibody formation. Immunology 49 (1983) 37-44
9. Brewer J.M., Tetley L., Richmond J., Liew F.Y., and Alexander J. Lipid vesicle size determines the Th1 or Th2 response to entrapped antigen. J Immunol 161 (1998) 4000-4007
10. Mann J.F.S., Shakir E., Carter K.C., Mullen A.B., Alexander J., and Ferro V.A. Lipid vesicle size of an oral influenza vaccine delivery vehicle influences the Th1/Th2 bias in the immune response and protection against infection. Vaccine (2009) 10.1016/j.vaccine.200903040
11. Owais M., and Gupta C.M. Liposome-mediated cytosolic delivery of macromolecules and its possible use in vaccine development. Eur J Biochem 267 (2000) 3946-3956
12. Kraajieveld C.A., Schilham M., Jansen J., Benaissa-Trouw B., Harmsen M., Houte A.J., et al. The effect of liposomal charge on the neutralising antibody response against inactivated encephalomyocarditis and Semliki Forest viruses. Clin Exp Immunol 56 (1984) 509-514
13. Badiee A., Jaafari M.R., Khamesipour A., Samiei A., Soroush D., Kheiri M.T., et al. The role of liposome charge on immune response generated in BALB/c mice immunized with recombinant major surface glycoprotein of Leishmania (rgp63). Exp Parasitiol 121 (2009) 362-369
14. Karmali P.P., and Chaudhuri A. Cationic liposomes as non-viral carriers of gene medicines: resolved issues, open questiones, and future promises. Med Res Rev 27 (2007) 696-722
15. Templeton N.S. Cationic liposomes as in vivo delivery vehicles. Curr Med Chem 10 (2003) 975-983
16. Wasungu L., and Hoekstra D. Cationic lipids, lipoplexes and intracellular delivery of genes. J Control Release 116 (2006) 255-264
17. Zabner J., Fasbender A.J., Moninger T., Poellinger K.A., and Welsh M.J. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 270 (1995) 18997-19007
18. Xu Y., and Szoka F.C. Mechanism of DNA release from cationic liposome/DNA complexes used in cell transfection. Biochemistry 35 (1996) 5616-5623
19. Hoekstra D., Rejman J., Wasungu L., Shi F., and Zuhorn I. Gene delivery by cationic lipids: in and out of an endosome. Biochem Soc Trans 35 (2007) 68-71
20. Simberg D., Weisman S., Talmon Y., and Barenholz Y. DOTAP (and other cationic lipids): chemistry, biophysics, and transfection. Crit Rev Ther Drug Carrier Syst 24 (2004) 257-317
21. Yan W., Chen W., and Huang L. Mechanism of adjuvant activity of cationic liposome: phosphorylation of a MAP kinase. ERK and induction of chemokines. Mol Immunol 44 (2007) 3672-3681
22. Korsholm K.S., Agger E.M., Foged C., Christensen D., Dietrich J., Andersen C.S., et al. The adjuvant mechanism of cationic dimethyldioctadecylammonium liposomes. Immunology 121 (2007) 216-226
23. Koynova R., Tarahovsky Y.S., Wang L., and MacDonald R.C. Lipoplex formulation of superior efficacy exhibits high surface activity and fusogenicity, and readily releases DNA. Biochim Biophys Acta 1768 (2007) 375-386
24. Fletcher S., Ahmad A., Perouzel E., Jorgensen M.R., and Miller A.D. A dialkynoyl analogue of DOPE improves gene transfer of lower-charged, cationic lipoplexes. Org Biomol Chem 4 (2006) 196-199
25. Brgles M., Jurašin D., Sikirić-Dutour M., Frkanec R., and Tomašić J. Entrapment of ovalbumin into liposomes-factors affecting entrapment efficiency, liposome size, and zeta potential. J Liposome Res 18 (2008) 235-248
26. Tomašić J., Hanzl-Dujmović I., Špoljar B., Vranešić B., Šantak M., and Jovičić A. Comparative study of the effects of peptidoglycan monomer and structurally related adamantyltripeptides on humoral immune response to ovalbumin in mouse. Vaccine 18 (2000) 1236-1243
27. Halassy B., Krstanović M., Frkanec R., and Tomašić J. Adjuvant activity of peptidoglycan monomer and its metabolic products. Vaccine 21 (2003) 971-976
28. Halassy B., Vdović V., Habjanec L., Lang Balija M., Gebauer B., Sabioncello A., et al. Effectivness of novel PGM-containing incomplete Seppic adjuvants in rabbits. Vaccine 25 (2007) 3475-3481
29. Habjanec L., Halassy B., Vdović V., Lang Balija M., and Tomašić J. Comparison of mouse and rabbit model for the assesment of strong PGM-containing oil-based adjuvants. Vet Immunol Immunopathol 121 (2008) 232-400
30. Frkanec R., Travaš D., Krstanovic M., Halassy Špoljar B., Ljevaković D., Vranešić B., et al. Entrapment of peptidoglycans and adamantyltripeptides into liposomes: an HPLC assay for determination of encapsulation efficiency. J Liposome Res 13 (2003) 279-294
31. Kulkarni S.B., Betageri G.V., and Singh M. Factors affecting microencapsulation of drugs in liposomes. J Microencapsul 12 (1995) 229-246
32. Brgles M., Mirosavljević K., Noethig-Laslo V., Frkanec R., and Tomašić J. Spin-labelling study of interactions of ovalbumin with multilamellar liposomes and specific anti-ovalbumin antibodies. Int J Biol Macromol 40 (2007) 312-318
33. Kutzler M.A., and Weiner D.B. DNA vaccines: ready for prime time?. Nat Rev Genet 9 (2008) 776-788
34. Liu M. DNA vaccine: a review. J Internal Med 253 (2003) 402-410
35. Kunisawa J., Nakagawa S., and Mayumi T. Pharmacotherapy by intracellular delivery of drugs using fusogenic liposomes: application to vaccine development. Adv Drug Delivery Rev 52 (2001) 177-186
36. Chikh G., and Schutze-Redelmeier M.-P. Liposomal delivery of CTL epitopes to dendritic cells. Biosci Rep 22 (2002) 339-353
37. Foged C., Arigita C., Sundblad A., Jiskoot W., Storm G., and Frokjaer S. Interaction of dendritic cells with antigen-containing liposomes: effect of bilayer composition. Vaccine 22 (2004) 1903-1913
38. Koltover I., Salditt T., Rädler J.O., and Safinya C.R. An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. Science 281 (1998) 78-81
39. Lonez C., Vandenbranden M., and Ruysschaert J.-M. Cationic liposomal lipids: from gene carriers to cell signaling. Prog Lipid Res 47 (2008) 340-347